Society
Lenacapavir as potential solution to Kenya's rising HIV infections
The News
Kenya's 2016 rollout of daily oral PrEP has hit a structural ceiling, with new HIV infections surging 19 per cent to 20,000 cases last year despite over 544,000 people initiated on the treatment. The article questions whether lenacapavir could address the "daily pill" model's failure to protect vulnerable populations.
25 April 2026 · The Standard →